Applying sensitivity and specificity estimates from the present meta-analysis to results from the 1998 and 2000 NHIS
| . | Time frame (y) . | Ages . | Observed prevalence . | Se . | Sp . | Adjusted prevalence . |
|---|---|---|---|---|---|---|
| Mammogram | 2 | 40+ | 70 | 0.95 | 0.61 | 56 |
| Pap smear | 3 | 25+ | 82 | 0.93 | 0.48 | 74 |
| PSA test | 1 | 50+ | 41 | 0.71 | 0.73 | 32 |
| FOBT (women) | 2 | 50+ | 26 | 0.82 | 0.78 | <10 |
| FOBT (men) | 2 | 50+ | 29 | 0.82 | 0.78 | 11 |
| Endoscopy (women) | 3 | 50+ | 10 | 0.79 | 0.90 | <10 |
| Endoscopy (men) | 3 | 50+ | 19 | 0.79 | 0.90 | 13 |
| . | Time frame (y) . | Ages . | Observed prevalence . | Se . | Sp . | Adjusted prevalence . |
|---|---|---|---|---|---|---|
| Mammogram | 2 | 40+ | 70 | 0.95 | 0.61 | 56 |
| Pap smear | 3 | 25+ | 82 | 0.93 | 0.48 | 74 |
| PSA test | 1 | 50+ | 41 | 0.71 | 0.73 | 32 |
| FOBT (women) | 2 | 50+ | 26 | 0.82 | 0.78 | <10 |
| FOBT (men) | 2 | 50+ | 29 | 0.82 | 0.78 | 11 |
| Endoscopy (women) | 3 | 50+ | 10 | 0.79 | 0.90 | <10 |
| Endoscopy (men) | 3 | 50+ | 19 | 0.79 | 0.90 | 13 |
NOTE: Mammogram, Pap smear, and PSA prevalence estimates are from the 2000 NHIS; FOBT and endoscopy prevalence estimates are from the 1998 NHIS.